Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 USD | +0.33% | -4.76% | -6.83% |
05-14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
05-14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.83% | 214M | |
+11.92% | 116B | |
+12.09% | 106B | |
-9.02% | 23.89B | |
-2.53% | 21.58B | |
-10.95% | 18.96B | |
-40.50% | 16.96B | |
-13.73% | 16.33B | |
+6.60% | 14.14B | |
+31.56% | 12.02B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Ovid Therapeutics Inc. Appoints Jeff Rona as Chief Financial Officer